We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Training Device Improves Accuracy of Pooled Molecular Diagnostics

By LabMedica International staff writers
Posted on 09 Jul 2026

High-throughput molecular diagnostics have transformed infectious disease detection, but many workflows remain difficult to execute accurately without extensive training. More...

Sample pooling can cut per‑test costs and raise throughput, yet it is prone to transfer errors, cross‑contamination, and documentation lapses that compromise results. At the same time, shortages of trained personnel limit access to advanced testing in decentralized and mobile settings. A new study describes an interactive device that helps novices perform pooled nucleic acid amplification tests (NAATs) with high accuracy.

In work published in PNAS Nexus, researchers developed a “train‑and‑assist” device designed to upskill laboratory‑inexperienced users for sample pooling workflows. The system monitors a user’s progress through each step of pooling equal volumes from multiple specimens for NAATs that detect diverse infectious pathogens. It is presented as a way to expand reliable pooling beyond settings that have automated liquid handlers or specialized staff.

The device provides step‑by‑step guidance, tracks progress, and weighs each sample tube precisely to verify transfers. It delivers real‑time feedback when too much or too little sample is added and helps users correct mistakes that are still fixable. When an error is deemed uncorrectable, the system instructs the user to terminate the process. Built for broad accessibility, the apparatus uses low‑cost, off‑the‑shelf electronics, 3D‑printed modules, and open‑source systems, with a total estimated cost of about $600 per unit.

Performance was evaluated in a study of 48 participants, 37 of whom had little or no previous laboratory experience. Compared with paper instructions, the device enabled users to pool mock clinical samples with high accuracy, reduced uncorrected handling errors, improved volume‑transfer technique, and produced high‑quality pools. The authors indicate these gains were achieved while guiding novices through a standard pooling protocol.

According to the authors, such tools could make pooled NAATs logistically and financially feasible for large‑scale surveillance programs, including those that must estimate low disease prevalence and inform decisions about when mass drug administration can be stopped. The study was published in PNAS Nexus on July 7, 2026, under the title “A train‑and‑assist device that upskills novices to strengthen the workforce and expand diagnostic access.”


New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
New
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.